Results 11 to 20 of about 49 (49)

[Epidemiology of benign thyroid disorders in the adult population of the Republic of Belarus: analysis of nationwide statistics 2009 to 2019]. [PDF]

Probl Endokrinol (Mosk), 2022
Yakubouski SU, Kandratsenka HH, Salko OB, Kuz'menkova EI.   +3 more
europepmc   +1 more source

[The features of regulatory T-blood cells subpopulation and the level of CD25 expression in patients with Graves' disease in dynamics after radioactive iodine therapy]. [PDF]

Probl Endokrinol (Mosk), 2023
Dudina MA, Savchenko AA, Dogadin SA, Borisov AG, Belenyuk VD.   +4 more
europepmc   +1 more source

[T-lymphocytes phenotypic composition of peripheral blood in patients with Graves' disease undergoing conservative therapy with thiamazole]. [PDF]

Probl Endokrinol (Mosk), 2021
Dudina MA, Dogadin SA, Savchenko AA, Belenyuk VD.   +3 more
europepmc   +1 more source

[Thyrotoxicosis in a patient with Turner syndrome: radioactive iodine therapy]. [PDF]

Probl Endokrinol (Mosk), 2022
Guseinova RM, Prosvirnina AA, Korchagina MO, Trukhin AA, Sheremeta MS.   +4 more
europepmc   +1 more source

[Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development]. [PDF]

Probl Endokrinol (Mosk), 2023
Ermolaeva AS, Fadeev VV.
europepmc   +1 more source

[Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)]. [PDF]

Probl Endokrinol (Mosk), 2021
Troshina EA, Panfilova EA, Mikhina MS, Kim IV, Senyushkina ES, Glibka AA, Shifman BM, Larina AA, Sheremeta MS, Degtyarev MV, Rumyanstsev PO, Kuznetzov NS, Melnichenko GA, Dedov II.   +13 more
europepmc   +1 more source

[An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease]. [PDF]

Probl Endokrinol (Mosk), 2023
Perepelova MA, Zaitseva EL, Bessmertnaya EG, Grusha YO, Sviridenko NY, Galstyan GR.   +5 more
europepmc   +1 more source

[Thyrotropin-secreting pituitary adenomas: clinical features and results of treatment in 45 patients]. [PDF]

Probl Endokrinol (Mosk), 2023
Trukhina DA, Przhiyalkovskaya EG, Belaya ZE, Grigoriev AY, Azizyan VN, Mamedova EO, Rozhinskaya LY, Lapshina AM, Pigarova EA, Dzeranova LK, Platonova NM, Troshina EA, Melnichenko GA.   +12 more
europepmc   +1 more source

[Hypophysitis and reversible hypopituitarism developed after COVID-19 infection - a clinical case report]. [PDF]

Probl Endokrinol (Mosk), 2022
Gorbova NY, Vladimirova VP, Rozhinskaya LY, Belaya ZY.   +3 more
europepmc   +1 more source

[Immunogenetics of primary hyperaldosteronism: fundamental studies and their clinical prospects]. [PDF]

Probl Endokrinol (Mosk), 2022
Eristavi SK, Platonova NM, Troshina EA.
europepmc   +1 more source